Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial

Authors

David Staskin (ORCID: https://orcid.org/0000-0003-4972-765X)
Salim Mujais
Kenneth M. Peters (ORCID: https://orcid.org/0000-0001-9020-598X)
Janet Owens‐Grillo (ORCID: https://orcid.org/0009-0003-2457-2214)
Sender Herschorn (ORCID: https://orcid.org/0000-0001-8666-8236)
Eric Rovner (ORCID: https://orcid.org/0000-0003-3950-8752)
Elizabeth Thomas (ORCID: https://orcid.org/0000-0002-5224-1119)

Institutions

Tufts University (US)
Sunnybrook Health Science Centre (CA)
Medical University of South Carolina (US)
Oakland University (US)
University of Toronto (CA)
Health Sciences Centre (CA)
Sumitomo Dainippon Pharma (United States) (US)
Beaumont Hospital, Troy (US)

Publication Details

Journal: Neurourology and Urodynamics
Published: 2025-12-09
DOI: https://doi.org/10.1002/nau.70199
Primary Topic: Urinary Bladder and Prostate Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial

David Staskin, Salim Mujais, Kenneth M. Peters, Janet Owens‐Grillo et al.

Dec 9, 2025

Neurourology and Urodynamics

Urinary Bladder and Prostate Research

article

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial

David Staskin, Salim Mujais, Kenneth M. Peters, Janet Owens‐Grillo, Sender Herschorn, Eric Rovner, Elizabeth Thomas

December 9, 2025article en

Abstract

No abstract available for this paper.

Neurourology and UrodynamicsVol. 45(2)

Tufts University (US), Sunnybrook Health Science Centre (CA), Medical University of South Carolina (US), Oakland University (US), University of Toronto (CA), Health Sciences Centre (CA), Sumitomo Dainippon Pharma (United States) (US), Beaumont Hospital, Troy (US)

Openalex Percentile: Top 46%

Urinary Bladder and Prostate Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial — David Staskin, Salim Mujais, et al. · Neurourology and Urodynamics (2025) | TGRS Research Map | TGRS